The High Court on Tuesday asked the chief of the Directorate of Drug Administration, Abul Kalam Azad, to explain in two weeks why he would not be punished on charge of contempt of court for disobeying its directive, that had banned manufacture and marketing of eight substandard drugs, by allowing one of them to continue being manufactured.
The bench of Justice Md Ashfaqul Islam and Md Moazzem Hossain passed the order after hearing a contempt petition filed by the Human Rights and Peace for Bangladesh, stating that Abul Kalam Azad had banned seven medicines but allowed Diclofenac of Inova Pharmaceutical Ltd to be produced and marketed.
On January 27 another High Court bench, after hearing a writ petition filed by the rights organization, asked the director-general to take steps to stop production and marketing of the eight medicines which had been identified as substandard by laboratory tests. The court also ordered withdrawal of all those medicines from the market.
The seven other medicines that have been found to be substandard are Tetracycline capsule and Indox of North Bengal Pharmaceuticals Ltd, Sapox and Suspension Tempil of Alco Pharma Ltd, BT Mox 500 and BT Mox 250 of Bengal Techno Chemical Works Ltd and IndoTetra of Indobangla Pharmaceuticals.
The organization's lawyer, Manzill Murshid, told the court that the drug administration's director-general had committed contempt of court by not stopping production and marketing of Inova Pharmaceutical's Diclofenac.
Source: New Age
No comments:
Post a Comment